In solid cancers, inflammatory chemokines such as CCL5 together with their receptors have been shown to attract neutrophils and monocytes at the tumor site and reprogram them, leading to altered immune response (Mollica Poeta et al., 2019). This evidence concerns the gene CCL5 and neoplasm.